Wells Fargo & Company Integra Lifesciences Holdings Corp Transaction History
Wells Fargo & Company
- $507 Billion
- Q3 2025
A detailed history of Wells Fargo & Company transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Wells Fargo & Company holds 55,042 shares of IART stock, worth $646,743. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55,042
Previous 46,608
18.1%
Holding current value
$646,743
Previous $571,000
38.0%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding IART
# of Institutions
230Shares Held
79.9MCall Options Held
19.4KPut Options Held
0-
Black Rock Inc. New York, NY11.3MShares$132 Million0.01% of portfolio
-
Rubric Capital Management LP New York, NY7.65MShares$89.9 Million1.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.38MShares$86.7 Million0.0% of portfolio
-
Eaton Vance Management Boston, MA4.22MShares$49.5 Million0.26% of portfolio
-
Fuller & Thaler Asset Management, Inc. San Mateo, CA3.91MShares$46 Million0.2% of portfolio
About INTEGRA LIFESCIENCES HOLDINGS CORP
- Ticker IART
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 83,518,200
- Market Cap $981M
- Description
- Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...